FDA.reportPublic FDA data

letermovir 120 MG Oral Pellet [Prevymis]

RxCUI
2693193
RxNorm name
letermovir 120 MG Oral Pellet [Prevymis]
Display name
letermovir 120 MG Oral Pellet [Prevymis]
Full name
letermovir 120 MG Oral Pellet [Prevymis]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PREVYMISLETERMOVIRMerck Sharp & Dohme LLC1b49df80-be4f-47e0-a0b7-123f3e69395b2026-01-14Warnings, Adverse reactionsExact identifier
rxcui: 2693193

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1b49df80-be4f-47e0-a0b7-123f3e69395bPREVYMIS 120 MG Oral Pellet [PSN] · letermovir 120 MG Oral Pellet [Prevymis] [SBD] · Prevymis 120 MG Oral Pellet [SY]328These highlights do not include all the information needed to use PREVYMIS safely and effectively. See full prescribing information for PREVYMIS. PREVYMIS ® (letermovir) tablets, for oral use PREVYMIS ® (letermovir) oral pellets PREVYMIS ® (letermovir) injection, for intravenous use Initial U.S. Approval: 201720260114